World's Best Scientists 2026 revealed!
Peter B. Vermeulen

Peter B. Vermeulen

D-Index & Metrics

Medicine

D-Index
81
Citations
24507
World Ranking
16626
National Ranking
208

Peter B. Vermeulen publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Peter B. Vermeulen sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 407 publications — 40th percentile

40% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Peter B. Vermeulen D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Peter B. Vermeulen sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 81 D-Index — 19th percentile

19% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Peter B. Vermeulen is affiliated with the University of Antwerp in Belgium and has a primary research focus in Medicine and Biochemistry, Genetics, and Molecular Biology. Their work spans multiple subfields including Oncology, Cancer Research, Hepatology, Radiology, Nuclear Medicine and Imaging, and Pulmonary and Respiratory Medicine.

Their research covers topics such as:

  • Hepatocellular Carcinoma Treatment and Prognosis
  • Radiomics and Machine Learning in Medical Imaging
  • Cancer Cells and Metastasis
  • Cancer Genomics and Diagnostics
  • Colorectal Cancer Treatments and Studies
  • Pancreatic and Hepatic Oncology Research
  • Angiogenesis and VEGF in Cancer

Frequent publication venues for this scientist include:

  • European Journal of Surgical Oncology
  • British Journal of Cancer
  • Clinical & Experimental Metastasis
  • Cancer Research
  • European Journal of Cancer

Notable recent papers include:

  • "Claudin-2 promotes colorectal cancer liver metastasis and is a biomarker of the replacement type growth pattern" (2021, Communications Biology)
  • "Histopathological growth patterns of liver metastasis: updated consensus guidelines for pattern scoring, perspectives and recent mechanistic insights" (2022, British Journal of Cancer)
  • "Predicting 10-year survival after resection of colorectal liver metastases; an international study including biomarkers and perioperative treatment" (2022, European Journal of Cancer)
  • "Histopathological Growth Patterns and Survival After Resection of Colorectal Liver Metastasis: An External Validation Study" (2021, JNCI Cancer Spectrum)
  • "Molecular differences of angiogenic versus vessel co-opting colorectal cancer liver metastases at single-cell resolution" (2023, Molecular Cancer)

Frequent co-authors in their publications include:

  • Luc Dirix
  • Denis Larsimont
  • Cornelis Verhoef
  • Dirk J. Grünhagen
  • Steven Van Laere

Best Publications

  • Landscape of somatic mutations in 560 breast cancer whole-genome sequences

    Serena Nik-Zainal;Serena Nik-Zainal;Helen Davies;Johan Staaf;Manasa Ramakrishna

  • Quantification of angiogenesis in solid human tumours: an international consensus on the methodology and criteria of evaluation

    P. E. Vermeulen;G. Gasparini;S. B. Fox;Masakazu Toi

  • Second international consensus on the methodology and criteria of evaluation of angiogenesis quantification in solid human tumours.

    P.B. Vermeulen;G. Gasparini;S.B. Fox;C. Colpaert

  • Consensus guidelines for the use and interpretation of angiogenesis assays

    Patrycja Nowak-Sliwinska;Kari Alitalo;Elizabeth Allen;Andrey Anisimov

  • Circulating interleukin-6 predicts survival in patients with metastatic breast cancer.

    Roberto Salgado;Sara Junius;Ina Benoy;Peter Van Dam

  • International expert panel on inflammatory breast cancer: consensus statement for standardized diagnosis and treatment

    S. Dawood;S. D. Merajver;P. Viens;P. B. Vermeulen

  • Vascular integrin alpha(v)beta3: a new prognostic indicator in breast cancer.

    Giampietro Gasparini;Peter C. Brooks;Elia Biganzoli;Peter B. Vermeulen

  • Vessel co-option mediates resistance to anti-angiogenic therapy in liver metastases

    Sophia Frentzas;Sophia Frentzas;Eve Simoneau;Victoria L. Bridgeman;Peter B. Vermeulen

  • Increased Serum Interleukin-8 in Patients with Early and Metastatic Breast Cancer Correlates with Early Dissemination and Survival

    Ina H. Benoy;Roberto Salgado;Peter Van Dam;Katrien Geboers

  • Elevated levels of the angiogenic cytokines basic fibroblast growth factor and vascular endothelial growth factor in sera of cancer patients.

    L. Y. Dirix;P. B. Vermeulen;A. Pawinski;A. ProvÃ

  • VHL and HIF signalling in renal cell carcinogenesis

    Marcella M Baldewijns;Iris J H van Vlodrop;Peter B Vermeulen;Patricia M M B Soetekouw

  • Vessel co-option in cancer.

    Elizabeth A. Kuczynski;Elizabeth A. Kuczynski;Peter B. Vermeulen;Peter B. Vermeulen;Francesco Pezzella;Robert S. Kerbel;Robert S. Kerbel

  • Liver metastases from colorectal adenocarcinomas grow in three patterns with different angiogenesis and desmoplasia.

    Peter B. Vermeulen;Cecile Colpaert;Roberto Salgado;Ruben Royers

  • Tumor infiltrating lymphocytes: an intriguing player in the survival of colorectal cancer patients.

    Vanessa Deschoolmeester;Marc Baay;Eric Van Marck;Joost Weyler

  • Dysregulation of microRNAs in breast cancer and their potential role as prognostic and predictive biomarkers in patient management.

    Eleni van Schooneveld;Hans Wildiers;Ignace Vergote;Peter B Vermeulen

  • Increased Angiogenesis and Lymphangiogenesis in Inflammatory versus Noninflammatory Breast Cancer by Real-Time Reverse Transcriptase-PCR Gene Expression Quantification

    Ilse Van der Auwera;Steven J. Van Laere;Gert G. Van den Eynden;Ina Benoy

  • Plasma fibrin D-dimer levels correlate with tumour volume, progression rate and survival in patients with metastatic breast cancer.

    Luc Y Dirix;R Salgado;R Weytjens;C Colpaert

  • First international consensus on the methodology of lymphangiogenesis quantification in solid human tumours

    I Van der Auwera;Y Cao;J C Tille;M S Pepper

  • Expression profiling of cancerous and normal breast tissues identifies microRNAs that are differentially expressed in serum from patients with (metastatic) breast cancer and healthy volunteers

    Eleni van Schooneveld;Maartje C. A. Wouters;Ilse Van der Auwera;Dieter J. Peeters

  • Serum interleukin 6, plasma VEGF, serum VEGF, and VEGF platelet load in breast cancer patients.

    Ina Benoy;Roberto Salgado;Cecile Colpaert;Reinhilde Weytjens

Frequent Co-Authors

Luc Dirix
Luc Dirix GZA Ziekenhuizen Campus Sint-Augustinus
Eric Van Marck
Eric Van Marck University of Antwerp
Roberto Salgado
Roberto Salgado Peter MacCallum Cancer Centre
Marc Peeters
Marc Peeters University of Antwerp
adrian l harris
adrian l harris University of Oxford
Patrick Pauwels
Patrick Pauwels University of Antwerp
François Bertucci
François Bertucci Aix-Marseille University
Patrice Viens
Patrice Viens Aix-Marseille University
Gunilla Høyer-Hansen
Gunilla Høyer-Hansen University of Copenhagen

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you're exploring a future in medicine, there are many related online degrees and career pathways to consider. For those interested in nursing but concerned about entrance exams, there's an increasing number of nursing schools that don't require teas or hesi. This can make starting your nursing career more accessible.

For those drawn to healthcare leadership, earning a health care administration degree online can pave the way to jobs in hospital management, policy, and public health.

Nurses seeking to advance their roles may pursue specialized bridge programs, such as the asn to fnp pathway, which enables registered nurses to transition into Family Nurse Practitioner roles more efficiently.

Those interested in wellness and preventive care should consider an online bachelor's in nutrition. This qualification opens doors to careers in dietetics, public health, research, and education.

Online health degrees are flexible and increasingly respected, offering multiple routes to rewarding careers in the healthcare sector.

Best Scientists Citing Peter B. Vermeulen

Trending Scientists

Recently Published Articles